OAK

6.67%

6.4¢ oakridge international limited

Time for a new thread, page-2

First 2 Last

Share
Profile

Follow
scar76

2,315 Posts.

59

24/01/18

15:53

Post #: 30536899
Share

Originally posted by elit ↑

Ok lot of unhappy shareholders and ex-shareholders and share price tells a story. There are many reasons why specs fail.....

XPED have not been successful to date....that is obvious. Some concerns about goings on etc and past decisions and executive / management quality. I have them too.

But point taken from Madmin that until ASX or ASIC find anything that is untoward, and not sure if got a inference nothing been found.....one might have to accept there actually might not be the smoking gun some believe. So things like Agean pal yes I get that- timing of those family related party share sales unfortunate but equally not sure is illegal. Does not mean I still like it but we have to work with the confines of what is legal and what is illegal.

I think time has come to look at current woeful share price and understand if something is salvageable. I personally am bored of the past as I understand it all and hence support a class action if lawyers believe there is something there to pursue, but I am getting a picture despite lot of ASIC traffic that perhaps it might not just be there. Something we might need to accept and fact we just invested / traded badly in a spec stock that is in the majority that don't do very well.

I would like to see this thread move away from all the past stuff personally as we know that is priced in and more about whether from current levels could be a bag or two in it as a spec stock. As the latest t20 someone posted showed a lot of insiders loading up including some noteable past t20 holders who were on from XPE Mark 1 pump.....looking for Mark 2 pump e.g Wobbly investments.

I think despite the noise something is brewing.....would be good to get some focus on that.

Expand

Any value to be found here will be on the back of JCT, ADRC/XERTS IP has no revenue related value but weighs heavily on the SP. Once that is removed this will bag from here.

XPE Price at posting: 0.7¢ Sentiment: None Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

HotCopper Highlights: Your most watched stocks for Week 46, 2024

First 2 Last

Add OAK (ASX) to my watchlist

(20min delay)
Last 6.4¢		Change 0.004(6.67%)		Mkt cap ! $1.727M

Open	High	Low	Value	Volume
6.4¢	6.4¢	6.4¢	$513	8.021K

Buyers (Bids)

No.	Vol.	Price($)
2	14135	6.0¢

Sellers (Offers)

Price($)	Vol.	No.
6.5¢	28474	1

View Market Depth

No.	Vol.	Price($)
2	14135	0.060
1	100000	0.059
1	82000	0.055
1	55000	0.053
1	100000	0.046

Price($)	Vol.	No.
0.065	28474	1
0.095	20000	1
0.105	1524	1
0.175	22450	1
0.180	30000	1

Last trade - 12.20pm 15/11/2024 (20 minute delay)

OAK (ASX) Chart

Time for a new thread, page-2

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Cyclone signs MOU with Vale for development of Iron Bear play

Banshee's historic trenches prove rich in antimony and gold for GDM

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Time for a new thread, page-2

Top Stories

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Cyclone signs MOU with Vale for development of Iron Bear play

Banshee's historic trenches prove rich in antimony and gold for GDM

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

HotCopper Highlights: Your most watched stocks for Week 46, 2024

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News